Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
Individuals with Down syndrome have a 90% lifetime risk of developing Alzheimer’s disease.
The METabolic Health, Lifestyle, and Risk of Co-Occurring Health Conditions in Down Syndrome (MET-DS) study is part of the NIH INCLUDE Project (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndrome) and its Collaboration for Down Syndrome Progress (CDP) Program—national initiatives working to improve the health and quality of life of people with …
When Heather Huismann was in middle school she called the police on her teacher. “He was not teaching me very well,” Heather says.
NOTE: Each individual interviewed for this story stated their preference between person-first or identity-first language. The language used reflects the preference of each person. Researchers interviewed use identity-first language in alignment with the preferences of many of those in the autistic community. Who is considered an expert in autism? Or cerebral palsy? Or Down syndrome? …
Sigan Hartley, 100 Women Distinguished Chair in Human Ecology and Human Development & Family Studies professor, and a team of researchers have received a $9 million grant from the National Institutes of Health (NIH).
AT(N) biomarker profiles and Alzheimer’s disease in People with Down syndrome
Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), Charcot-Marie-Tooth disease, and retinitis pigmentosa all have different manifestations and affect different body functions, but they are all connected by one mechanism: neurodegeneration.
Allison and Amber Westemeier get excited every time they take a trip to the Waisman Center from Oshkosh, WI.
The development of brain imaging techniques has helped us understand emotion, intellectual and developmental disabilities, and neurodegenerative diseases in ways we could not before.
Unintentional weight loss in people with Down syndrome may predict the onset of Alzheimer’s disease long before typical cognitive symptoms like memory loss and dementia are apparent.
